Retraction Note: Alz Res Ther 13, 37 (2021)
https://doi.org/10.1186/s13195-021-00769-9
The Editors-in-Chief have retracted this article at the authors' request. After publication, concerns were raised regarding a number of cases of image overlap within the Figures, which the authors addressed by a Correction [1]. However, subsequent concerns have been raised about further image similarities within the article, as well as with previous studies. Specifically:
Fig. 3b 5xFAD + Veh CAI 12-month-old group image appears highly similar to an image representing the same group in [2].
In Fig. 3B, 5xFAD + SCLP Cortex and Entorhinal cortex images appear to originate from the same sample.
In Fig. 3E, the beta-tubulin blots presented for the cortex 6- and 12-month-old groups appear highly similar; the beta-tubulin blot image for hippocampus in the 6-month-old group appears highly similar to that representing beta-tubulin in the 12-month-old group in Figs. 5F and 7A.
The updated Fig. 4G 5xFAD Primary 6-month-old group image appears to overlap with Fig. 4I 5xFAD Secondary 12-month-old group.
The top beta-tubulin blot in Fig. 6F appears highly similar to the beta-tubulin (hippocampus) blot in Fig. 7A.
The blots in Fig. S2I appear highly similar to those in Fig. 3D of [3, now retracted].
Fig. S5A appears highly similar to the Merged 5xFAR + SLCP (2d) image in Fig. 1B of [3, now retracted].
Despite internal data validation, the authors no longer have sufficient confidence in the findings of this study.
All authors agree to this retraction.
Contributor Information
Panchanan Maiti, Email: maiti1p@cmich.edu.
Gary L. Dunbar, Email: dunba1g@cmich.edu
References
- 1.Maiti P, Bowers Z, Bourcier-Schultz A, et al. Correction to: Preservation of dendritic spine morphology and postsynaptic signaling markers after treatment with solid lipid curcumin particles in the 5xFAD mouse model of Alzheimer’s amyloidosis. Alz Res Ther. 2022;14:42. doi: 10.1186/s13195-022-00980-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Maiti P, Manna J, Burch ZN, et al. Ameliorative Properties of Boronic Compounds in In Vitro and In Vivo Models of Alzheimer’s Disease. Int J Mol Sci. 2020;21(18):6664. doi: 10.3390/ijms21186664. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Maiti P, Paladugu L, Dunbar GL. RETRACTED ARTICLE: Solid lipid curcumin particles provide greater anti-amyloid, anti-inflammatory and neuroprotective effects than curcumin in the 5xFAD mouse model of Alzheimer’s disease. BMC Neurosci. 2018;19:7. doi: 10.1186/s12868-018-0406-3. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]